Aetna Will Not Expand Obamacare Business in 2017
Aetna Inc said on Tuesday that it no longer planned to expand its Obamacare business next year and would sell some Medicare Advantage assets as it fights to gain antitrust regulators' approval for its takeover of Humana Inc .
Aetna Will Not Expand Obamacare Business in 2017
Aetna Inc said on Tuesday that it no longer planned to expand its Obamacare business next year and would sell some Medicare Advantage assets as it fights to gain antitrust regulators' approval for its takeover of Humana Inc .
Report: Biogen Targeted as Takeover Target
Biotechnology giant Biogen Inc has drawn takeover interest from drug companies including Merck & Co Inc and Allergan Plc, the Wall Street Journal reported, citing people familiar with the matter.
Mayor Giminez: Miami tourist areas are safe
Zika in Florida
The Critical Money Considerations You Should Make in Your 60s
The average retirement age in the United States is 63, according to U.S. Census Bureau data. If you are part of that trend, get ready to have your financial world turned upside down in your 60s.
The Critical Money Considerations You Should Make in Your 60s
The average retirement age in the United States is 63, according to U.S. Census Bureau data. If you are part of that trend, get ready to have your financial world turned upside down in your 60s.
Aetna Scraps Obamacare Business Expansion Plans
Aetna said it intended to withdraw plans to expand its Obamacare business next year, and the U.S. health insurer announced the sale of some Medicare Advantage assets to get antitrust nod for its takeover of Humana.
Is the Zika Virus a Threat to the United States?
Dr. Anthony Fauci discusses how the Zika virus could impact the United States.
Is the Zika Virus a Threat to the United States?
Dr. Anthony Fauci discusses how the Zika virus could impact the United States.
Pfizer's 2Q Profit Tops Expectations
Pfizer reported better-than-expected quarterly revenue and profit, driven by sales of newer drugs and the acquisition of hospital products company Hospira.
CVS's Profit Beats Estimates on Pharma Business
CVS Health, the No. 2 U.S. drugstore chain by store count, reported better-than-expected profit helped by strong demand for its pharmacy benefit management (PBM) services.
CVS's Profit Beats Estimates on Pharma Business
CVS Health, the No. 2 U.S. drugstore chain by store count, reported better-than-expected profit helped by strong demand for its pharmacy benefit management (PBM) services.
August is Rough for Stocks, But 5 Dividend Payers Look Good
August usually gives investors indigestion but these dividend payers may be good buys.
Express Scripts Says Valeant, Lilly, Bristol Drugs to Lack Coverage
Express Scripts Holding said on Monday it would add a handful of medicines in 2017 to its list of drugs that are excluded from insurance coverage.
Theranos CEO: We're Working to Address Problems
The chief executive of the embattled blood testing company said the privately held firm is working diligently to rectify all of its outstanding issues involving its product and laboratory operations.
Zika cases on rise in U.S.
Zika virus in U.S.
Florida Has Identified 10 More Zika Cases; Calls in Feds for Help
The state of Florida has identified 10 more cases of Zika virus caused by local mosquitoes and has asked the U.S. Centers for Disease Control and Prevention to send in experts to help with the investigation of the outbreak.
Florida Cases Seen as First Sign Zika Transmitted Locally in U.S.
Florida authorities on Friday reported what is believed to be the first evidence of local Zika transmission in the continental United States, concluding that mosquitoes likely infected four people with the virus that can cause rare but serious birth defects.
Merck Posts Better-Than-Expected Profit, Revenue
Merck & Co reported better-than-expected quarterly profit and revenue, helped by growing demand for its new cancer treatment, Keytruda.